Oncology Research and Treatment

Oncology Research and Treatment
期刊缩写:
ONCOL RES TREAT
影响因子:
2
ISSN:
print: 2296-5270
on-line: 2296-5262
研究领域:
ONCOLOGY
h-index:
43
自引率:
0.00%
Gold OA文章占比:
17.65%
原创研究文献占比:
81.08%
SCI收录类型:
Science Citation Index Expanded (SCIE) || Scopus (CiteScore)
期刊介绍英文:
With the first issue in 2014, the journal ''Onkologie'' has changed its title to ''Oncology Research and Treatment''. By this change, publisher and editor set the scene for the further development of this interdisciplinary journal. The English title makes it clear that the articles are published in English – a logical step for the journal, which is listed in all relevant international databases. For excellent manuscripts, a ''Fast Track'' was introduced: The review is carried out within 2 weeks; after acceptance the papers are published online within 14 days and immediately released as ''Editor’s Choice'' to provide the authors with maximum visibility of their results. Interesting case reports are published in the section ''Novel Insights from Clinical Practice'' which clearly highlights the scientific advances which the report presents.
CiteScore:
CiteScoreSJRSNIPCiteScore排名
3.20.5210.553
学科
排名
百分位
大类:Medicine
小类:Hematology
78 / 137
43%
大类:Medicine
小类:Oncology
242 / 404
40%
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
171 / 230
25%
发文信息
中科院SCI期刊分区
大类 小类 TOP期刊 综述期刊
4区 医学
4区 肿瘤学 ONCOLOGY
WOS期刊分区
学科分类
Q3ONCOLOGY
历年影响因子
2015年1.3330
2016年1.6670
2017年1.4940
2018年1.4830
2019年1.9670
2020年2.8250
2021年2.8440
2022年2.4000
2023年2.0000
历年发表
2012年4
2013年48
2014年175
2015年167
2016年191
2017年196
2018年187
2019年151
2020年128
2021年135
2022年84
投稿信息
出版语言:
English
出版国家(地区):
GERMANY
出版商:
S. Karger AG
编辑部地址:
ALLSCHWILERSTRASSE 10, BASEL, SWITZERLAND, CH-4009

Oncology Research and Treatment - 最新文献

Survivorship in CAR T-cell Therapy Recipients: Infections, Secondary Malignancies, and Non-Relapse Mortality.

Pub Date : 2024-11-19 DOI: 10.1159/000542631 Tobias Tix, Marion Subklewe, Michael von Bergwelt-Baildon, Kai Rejeski

Palbociclib in combination with either aromatase inhibitors or fulvestrant for patients with advanced HR+/HER2- breast cancer in Germany - Final results of the phase 2 multicohort INGE-B trial.

Pub Date : 2024-11-15 DOI: 10.1159/000542459 Manfred Welslau, Karin Potthoff, Matthias Zaiss, Lothar Müller, Cosima Brucker, Christoph Salat, Michael Untch, Johannes Meiler, Diana Lüftner, Anja Welt, Steffen Dörfel, Volker Hagen, Alexander Stein, Rüdiger Liersch, Thomas Kuhn, Hans Ulrich Siebenbach, Gerlinde Bing, Corinne Vannier, Norbert Marschner, Katja Gratzke

Sex-disaggregated analysis of central venous catheter-related bloodstream infections in patients with cancer.

Pub Date : 2024-11-11 DOI: 10.1159/000542535 Enrico Schalk, Alva Seltmann, Boris Böll, Nicola Giesen, Judit Grans-Siebel, Oliver Kriege, Julia Lanznaster, Antrea Minti, Jan-Hendrik Naendrup, Julia Neitz, Jens Panse, Martin Schmidt-Hieber, Ruth Seggewiss-Bernhardt, Daniel Teschner, Philipp Weber, Kai Wille, Marie von Lilienfeld-Toal, Marcus Hentrich
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信